Work

Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?

Year: 2014
Type: editorial
Abstract: Dysregulation of apoptosis through alterations in the B-cell lymphoma/leukemia 2 (Bcl-2) family of proteins is a hallmark of the pathophysiology of indolent non-Hodgkin lymphomas (NHLs). The most c...
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2138674793
Cites: 10
Cited by: 1
Related to: 10